Literature DB >> 15788208

Evolution of clinical behaviour in Crohn's disease: predictive factors of penetrating complications.

C Papi1, V Festa, C Fagnani, A Stazi, G Antonelli, A Moretti, M Koch, L Capurso.   

Abstract

BACKGROUND AND AIMS: Crohn's disease is a heterogeneous entity. The Vienna Classification defines three different clinical patterns: 'non-stricturing, non-penetrating', 'stricturing' and 'penetrating'. Aim of this study was to assess the change in clinical behaviour over time and to evaluate whether an evolution towards penetrating complications can be predicted.
METHODS: A total of 139 patients with non-penetrating behaviour at the time of diagnosis were included. The mean follow-up was 4.84 years (range 1-23.2 years). The clinical behaviour, according to the Vienna Criteria, was assessed at the diagnosis and at the end of follow up. Statistical analysis was performed by means of the Kaplan-Meier method and standard logistic regression analysis.
RESULTS: The cumulative probability of a change in clinical behaviour was 22, 38 and 63% at 3, 6 and 12 years, respectively, and the cumulative probability of developing penetrating complications was 22, 33 and 55% at 3, 6 and 12 years, respectively. Young age at diagnosis (<40 years) and a stricturing behaviour are independent risk factors of developing major penetrating complications (internal fistula, mass or abscess): OR=6.0, 95% CI 1.1-30.5; OR=4.0, 95% CI 1.5-10.9, respectively, but not perianal disease.
CONCLUSIONS: The behavioural classification of Crohn's disease is a dynamic model in which each status should be considered as not fixed but evolutive. Perianal disease should be considered a distinct pattern of penetrating behaviour.

Entities:  

Mesh:

Year:  2005        PMID: 15788208     DOI: 10.1016/j.dld.2004.10.012

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  8 in total

1.  Predictors of aggressive inflammatory bowel disease.

Authors:  Andres J Yarur; Sebastian G Strobel; Amar R Deshpande; Maria T Abreu
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-10

Review 2.  Recurrence rates in Crohn's disease: predicting the future and predicting the past.

Authors:  D B Sachar
Journal:  Gut       Date:  2006-08       Impact factor: 23.059

Review 3.  Crucial steps in the natural history of inflammatory bowel disease.

Authors:  Giovanni Latella; Claudio Papi
Journal:  World J Gastroenterol       Date:  2012-08-07       Impact factor: 5.742

4.  Diagnostic performance of PET/MR in the evaluation of active inflammation in Crohn disease.

Authors:  Onofrio Antonio Catalano; Vincent Wu; Umar Mahmood; Alberto Signore; Mark Vangel; Andrea Soricelli; Marco Salvatore; Debra Gervais; Bruce R Rosen
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-02-05

5.  What can we learn from inflammatory bowel disease in developing countries?

Authors:  Sunny H Wong; Siew C Ng
Journal:  Curr Gastroenterol Rep       Date:  2013-03

Review 6.  Surgery and diagnostic imaging in abdominal Crohn's disease.

Authors:  Fiorenzo Botti; Flavio Caprioli; Diego Pettinari; Alberto Carrara; Andrea Magarotto; Ettore Contessini Avesani
Journal:  J Ultrasound       Date:  2013-10-16

7.  Earlier Anti-Tumor Necrosis Factor Therapy of Crohn's Disease Correlates with Slower Progression of Bowel Damage.

Authors:  Hinaben Panchal; Mathilde Wagner; Manjil Chatterji; Bachir Taouli; Russell McBride; Jeromy R Patterson; Ryan Ungaro; Marla Dubinsky; Judy Cho; David B Sachar
Journal:  Dig Dis Sci       Date:  2019-01-03       Impact factor: 3.199

8.  Factors associated with disease evolution in Greek patients with inflammatory bowel disease.

Authors:  Constantinos Chatzicostas; Maria Roussomoustakaki; Spiros Potamianos; Gregorios Paspatis; Ioannis Mouzas; John Romanos; Helen Mavrogeni; Elias Kouroumalis
Journal:  BMC Gastroenterol       Date:  2006-07-25       Impact factor: 3.067

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.